SEAGULL HEALTH
Your health,We care!
Disitamab Vedotin for Injection is characterized by precise targeted tumor cell killing, significant efficacy in gastric cancer and urothelial carcinoma refractory to multiple lines of treatment, and a controllable safety profile.
AuthenticGuaranteeFast DeliveryPrivacy Disitamab vedotin is an anti-HER2 antibody-drug conjugate (ADC). It is mainly indicated for patients with advanced solid tumors confirmed to have HER2···【Read More】
Update: 10 Feb,2026Source: Haiou HealthViews: 80
Disitamab vedotin is a targeted antibody-drug conjugate (ADC) indicated for the treatment of HER2-expressing locally advanced or metastatic solid tumo···【Read More】
Update: 10 Feb,2026Source: Haiou HealthViews: 76
Disitamab Vedotin for Injection is a targeted anticancer agent, mainly used for the treatment of advanced solid tumors with HER2 expression. Common si···【Read More】
Update: 10 Feb,2026Source: Haiou HealthViews: 77
The recommended dose of Disitamab Vedotin is generally 2.5 mg/kg every 2 weeks, administered via intravenous infusion. The specific dosage should be a···【Read More】
Update: 10 Feb,2026Source: Haiou HealthViews: 80
Disitamab vedotin is a novel targeted therapeutic agent whose active ingredient is anti-HER2 antibody. It acts by disrupting the internal structural s···【Read More】
Update: 09 Feb,2026Source: Haiou HealthViews: 80
Disitamab vedotin is a HER2‑targeted antibody‑drug conjugate (ADC). It acts by specifically binding to the HER2 protein on the surface of tumor cells ···【Read More】
Update: 10 Feb,2026Source: Haiou HealthViews: 72
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH
